Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Gamida Cell $20 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
UMB Financial $110 million notes offering
The fixed-to-fixed-rate investment-grade notes are due 2032
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market
LiveWire $1.77 billion merger with AEA-Bridges Impact
We advised several financial institutions on the de-SPAC transaction of the Harley-Davidson division
JBS USA $2 billion senior notes offering and tender offer
The notes are due 2028, 2033 and 2052
Iris Energy $100 million equity line financing
We advised Iris Energy on the transaction
Development Bank of Japan program update and $600 million senior notes offering
We advised DBJ on its global MTN program update and sustainability bond offering
JPMorgan Chase medium-term note program
We advised JPMorgan Chase on the euro note program
EnVen Energy $1.1 billion acquisition by Talos Energy
We are advising EnVen Energy on the transaction